Nakhjavani, M.; Smith, E.; Palethorpe, H.M.; Tomita, Y.; Yeo, K.; Price, T.J.; Townsend, A.R.; Hardingham, J.E.
Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models. Pharmaceuticals 2021, 14, 633.
https://doi.org/10.3390/ph14070633
AMA Style
Nakhjavani M, Smith E, Palethorpe HM, Tomita Y, Yeo K, Price TJ, Townsend AR, Hardingham JE.
Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models. Pharmaceuticals. 2021; 14(7):633.
https://doi.org/10.3390/ph14070633
Chicago/Turabian Style
Nakhjavani, Maryam, Eric Smith, Helen M. Palethorpe, Yoko Tomita, Kenny Yeo, Tim J. Price, Amanda R. Townsend, and Jennifer E. Hardingham.
2021. "Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models" Pharmaceuticals 14, no. 7: 633.
https://doi.org/10.3390/ph14070633
APA Style
Nakhjavani, M., Smith, E., Palethorpe, H. M., Tomita, Y., Yeo, K., Price, T. J., Townsend, A. R., & Hardingham, J. E.
(2021). Anti-Cancer Effects of an Optimised Combination of Ginsenoside Rg3 Epimers on Triple Negative Breast Cancer Models. Pharmaceuticals, 14(7), 633.
https://doi.org/10.3390/ph14070633